Approve. OMB
will be consulting with OST staff to determine the status of
sampling plans for MIS reporting required under previous terms of
clearance. In July, 1994, the OST Drug Office presented a sampling
approach covering RSPA that required MIS reporting from a
substantially smaller number of entities. We believe that in the
next cycle of reporting, the number of respondants should be
substantially reduced. This clearance is conditioned on submission
of a satisfactory sampling plan by September 1, 1997. Since
positive rates in the industry have been brought below the 1%
target, we also encourage further steps by RSPA to reduce
burdensome recordkeeping and reporting. For example, comments in
this docket detailed difficulties with gathering information from
contractors, some of whom were very small. RSPA is to be commended
for initiatives to reduce random testing to 25% and encouraging
electronic reporting.
Inventory as of this Action
Requested
Previously Approved
03/31/2000
03/31/2000
03/31/1997
1,713
0
1,713
12,809
0
12,809
0
0
0
Gas and hazardous liquid operators are
required to prepare an annual MIS drug test which includes the
results of the operator's anti-drug program.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.